Danaher (DHR) Growth Rates Comparisons to IT Infrastructure Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Danaher Corporation  (NYSE: DHR)
    Sector  Technology    Industry IT Infrastructure
   Industry IT Infrastructure
   Sector  Technology
 

Danaher Growth Comparisons

Select each growth Category to receive further Information





DHR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 5.54 % 18.6 % 26.03 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 5.28 % 1.72 % 0.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 4.56 % 13.48 % 18.01 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 1.33 % 4.28 % 5.85 % 2.61 %
Revenue 5 Year Average Growth 1.97 % 7.89 % 11.09 % 10.59 %


DHR's Growth Comparisons in II. Quarter 2026




Comparing 5.54% year on year top-line growth in the second quarter 2026, Danaher grew on the lower pace than the 18.6% rise in the IT Infrastructure industry and 26.03% Revenue increase in the Technology sector. Although both, the IT Infrastructure industry and the Technology sector posted higher gains than 10.9% overall market increase, Danaher was trailing overall market in the second quarter.

Comparing the company's Revenue to the first quarter results, sales were higher by 5.28% . On the yearly basis, average annual sales growth for Danaher is 1.97%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

DHR Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Recurring revenue
4.46 %
-
Nonrecurring revenue
-0.54 %
-
North America
-4.03 %
-
Western Europe
16.44 %
-
Other developed markets
2.16 %
-
High-growth markets
5.66 %
-
segments
3.66 %
-
Biotechnology
11.48 %
-
Biotechnology Recurring revenue
12.7 %
-
Biotechnology Nonrecurring revenue
0 %
-
Biotechnology North America
-3.5 %
-
Biotechnology Western Europe
28.27 %
-
Biotechnology Other developed markets
-10.94 %
-
Biotechnology High-growth markets
11.62 %
-
Life Sciences
3.39 %
-
Life Sciences Recurring revenue
5.9 %
-
Life Sciences Nonrecurring revenue
-1.84 %
-
Life Sciences North America
-4.44 %
-
Life Sciences Western Europe
7.94 %
-
Life Sciences Other developed markets
14.63 %
-
Life Sciences High-growth markets
8.95 %
-
Diagnostics
-1.31 %
-
Diagnostics Recurring revenue
-1.66 %
-
Diagnostics Nonrecurring revenue
2.21 %
-
Diagnostics North America
-4.02 %
-
Diagnostics Western Europe
7.75 %
-
Diagnostics Other developed markets
-5.49 %
-
Diagnostics High-growth markets
-0.78 %
-
Biotechnology segments
11.48 %
-
Life Sciences segments
3.39 %
-
Diagnostics segments
-1.31 %
-
Total
3.66 %
-


Growth Rates of DHR's Income in the second quarter 2026


DHR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 48.29 % 33.89 % 53.98 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) -16.15 % 29.15 % 4.15 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) 16.07 % 17.69 % 34.6 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 7.71 % 8.08 % 11.15 % 20.86 %
Operating Income 5 Year Avg. Change 2.08 % 9.13 % 17.87 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 56.76 % 29.01 % 82.46 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -15.45 % 25.16 % 15.11 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 17.52 % 16.43 % 50.15 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 8.52 % 6.91 % 17.19 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change -0.25 % 8.92 % -45.59 % -28.52 %

DHR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 56.76 % 51.71 % 82.8 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) -15.45 % 45.92 % 15.75 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 17.32 % 20.11 % 51.26 % 57.33 %
Sequential Net Income Change (Q2 TTM) 8.54 % 12.1 % 17.25 % 18.65 %
Net Income 5 Year Avg. Growth -0.18 % 8.71 % 18.04 % 22.96 %

DHR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 59.74 % 186.38 % 82.46 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -15.17 % 23.33 % 15.11 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 19.49 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 8.88 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 2.77 % -8.16 % -45.59 % -28.52 %



DHR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 59.74 % 236.77 % 82.8 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) -15.17 % 43.78 % 15.75 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 8.91 % - - 4.93 %
EPS Net 5 Year Avg. Change 3.1 % 8.71 % 18.04 % 22.96 %



Danaher showed respectable 59.74% year on year rise of EPS in the second quarter, but comparing unfavorably to the 236.77% surge in the IT Infrastructure industry and 82.8% EPS rise in the Technology sector. Comparing second quarter, income per share Danaher Corporation was trailing overall market not just IT Infrastructure industry.

Comparing the company's EPS to the first quarter results, income per share were lower by -15.17% . On the annual basis, average annual income per share growth for Danaher is 3.1%, while S & P 500's including only Businesses with the second quarter 2026 financial reports, average yearly income per share growth is 22.96% over the past five years.

DHR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 16.06 % 16.42 % 15.89 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) 16.59 % -37.45 % -15.66 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 12.42 % 22.3 % 20.73 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 3.31 % 1.14 % 8.66 % 15.75 %
Free Cash Flow 5 Year Avg. Change -0.47 % 8.74 % 10.99 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) 370.67 % - 53.98 % 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - -46.11 % 0.88 % 152.64 %
Net Cash Flow 5 Year Avg. Change - - 4.45 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 8.47 % 32.75 % 76.33 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 13.5 % -9.95 % 13 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -10.56 % 8.04 % 64.56 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 1.83 % 6.77 % 14.06 % 23.05 %
Capital Expenditures 5 Year Avg. Change 7.88 % 3.92 % 23.09 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.